Overview

Lumigan Versus Cosopt

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy
Phase:
Phase 4
Details
Lead Sponsor:
Pharmaceutical Research Network
Treatments:
Bimatoprost
Dorzolamide
Timolol